214 related articles for article (PubMed ID: 22569777)
1. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening.
Jung DW; Oh ES; Park SH; Chang YT; Kim CH; Choi SY; Williams DR
Mol Biosyst; 2012 Jul; 8(7):1930-9. PubMed ID: 22569777
[TBL] [Abstract][Full Text] [Related]
2. Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing.
Tonon F; Zennaro C; Dapas B; Carraro M; Mariotti M; Grassi G
Int J Pharm; 2016 Dec; 515(1-2):583-591. PubMed ID: 27989824
[TBL] [Abstract][Full Text] [Related]
3. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
4. Development of a vestibular schwannoma xenograft zebrafish model for in vivo antitumor drug screening.
Lee HJ; Yang YJ; Jeong S; Lee JD; Choi SY; Jung DW; Moon IS
Laryngoscope; 2016 Dec; 126(12):E409-E415. PubMed ID: 27242319
[TBL] [Abstract][Full Text] [Related]
5. U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model.
Guo M; Wei H; Hu J; Sun S; Long J; Wang X
Oncol Rep; 2015 Aug; 34(2):699-706. PubMed ID: 26035715
[TBL] [Abstract][Full Text] [Related]
6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
7. Identification of anti-cancer chemical compounds using Xenopus embryos.
Tanaka M; Kuriyama S; Itoh G; Kohyama A; Iwabuchi Y; Shibata H; Yashiro M; Aiba N
Cancer Sci; 2016 Jun; 107(6):803-11. PubMed ID: 27019404
[TBL] [Abstract][Full Text] [Related]
8. The zebrafish/tumor xenograft angiogenesis assay.
Nicoli S; Presta M
Nat Protoc; 2007; 2(11):2918-23. PubMed ID: 18007628
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
Xiao J; Glasgow E; Agarwal S
Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
[TBL] [Abstract][Full Text] [Related]
10. Rapid identification of antimicrometastases drugs using integrated model systems with two dimensional monolayer, three dimensional spheroids, and zebrafish xenotransplantation tumors.
Fu A; Peh YM; Ngan W; Wei N; Luo KQ
Biotechnol Bioeng; 2018 Nov; 115(11):2828-2843. PubMed ID: 30102771
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
12. Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk.
Tobia C; Gariano G; De Sena G; Presta M
Biochim Biophys Acta; 2013 Sep; 1832(9):1371-7. PubMed ID: 23357577
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
[TBL] [Abstract][Full Text] [Related]
14. Developing a Novel Embryo-Larval Zebrafish Xenograft Assay to Prioritize Human Glioblastoma Therapeutics.
Wehmas LC; Tanguay RL; Punnoose A; Greenwood JA
Zebrafish; 2016 Aug; 13(4):317-29. PubMed ID: 27158859
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic cancer drug using the zebrafish model.
Santoro MM
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1846-53. PubMed ID: 24903092
[TBL] [Abstract][Full Text] [Related]
16. PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway.
Ren Y; Zhou X; Qi Y; Li G; Mei M; Yao Z
Oncol Rep; 2012 Sep; 28(3):943-8. PubMed ID: 22710837
[TBL] [Abstract][Full Text] [Related]
17. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.
Garlich JR; De P; Dey N; Su JD; Peng X; Miller A; Murali R; Lu Y; Mills GB; Kundra V; Shu HK; Peng Q; Durden DL
Cancer Res; 2008 Jan; 68(1):206-15. PubMed ID: 18172313
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish xenograft models of cancer and metastasis for drug discovery.
Brown HK; Schiavone K; Tazzyman S; Heymann D; Chico TJ
Expert Opin Drug Discov; 2017 Apr; 12(4):379-389. PubMed ID: 28277839
[TBL] [Abstract][Full Text] [Related]
19. Improving zebrafish embryo xenotransplantation conditions by increasing incubation temperature and establishing a proliferation index with ZFtool.
Cabezas-Sainz P; Guerra-Varela J; Carreira MJ; Mariscal J; Roel M; Rubiolo JA; Sciara AA; Abal M; Botana LM; López R; Sánchez L
BMC Cancer; 2018 Jan; 18(1):3. PubMed ID: 29291719
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
